The presence of IGHG1 in human pancreatic carcinomas is associated with immune evasion mechanisms

X Li, R Ni, J Chen, Z Liu, M Xiao, F Jiang, C Lu - Pancreas, 2011 - journals.lww.com
Objectives: To investigate the expression of Igγ-1 chain C region (IGHG1) in human
pancreatic carcinomas and determine the biological function of IGHG1 expression in immune …

Increased α-tubulin1b expression indicates poor prognosis and resistance to chemotherapy in hepatocellular carcinoma

C Lu, J Zhang, S He, C Wan, A Shan, Y Wang… - Digestive diseases and …, 2013 - Springer
Background Hepatocellular carcinoma (HCC) is one of the leading causes of cancer deaths
worldwide. It is important to understand molecular mechanisms of HCC progression and to …

Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition

J Liu, C Lu, M Xiao, F Jiang, L Qu, R Ni - Biomedicine & Pharmacotherapy, 2017 - Elsevier
Background Recently, Accumulating evidence indicates that long noncoding RNAs (lncRNAs)
have been shown to have critical regulatory roles in human tumor biology and …

Micro RNA‐155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK 1 signalling pathway

…, N Tang, X Zeng, K Wu, C Ye, J Shi, C Lu… - Liver …, 2015 - Wiley Online Library
Background & Aims Epithelial‐mesenchymal transition ( EMT ) process and extracellular
signal‐regulated kinase 1 ( ERK 1) signalling pathway play pivotal roles in hepatic stellate cell ( …

Increased expression of glycinamide ribonucleotide transformylase is associated with a poor prognosis in hepatocellular carcinoma, and it promotes liver cancer cell …

X Cong, C Lu, X Huang, D Yang, X Cui, J Cai, L Lv… - Human Pathology, 2014 - Elsevier
Glycinamide ribonucleotide transformylase (GART) is a folate-dependent enzyme in the de
novo purine pathway that has been the target of antineoplastic intervention for almost 2 …

Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: Correlation with Skp2 …

Y Zhao, Q Tang, R Ni, X Huang, Y Wang, C Lu, A Shen… - Human pathology, 2013 - Elsevier
Early mitotic inhibitor-1 (Emi1) is a key cell-cycle regulator that promotes S-phase and M-phase
entry by inhibiting anaphase-promoting complex/cyclosome (APC/C) activity. …

[PDF][PDF] A tumor-specific super-enhancer drives immune evasion by guiding synchronous expression of PD-L1 and PD-L2

…, B Tao, Y Qin, H Chen, A Liu, M Chen, M Xiao, C Lu… - Cell reports, 2019 - cell.com
PD-L1 and PD-L2 are important targets for immune checkpoint blockade, but how tumor
cells achieve their expression remains to be addressed. Here, we find that PD-L1 and PD-L2 …

High NUSAP1 expression predicts poor prognosis in colon cancer

Z Liu, C Guan, C Lu, Y Liu, R Ni, M Xiao… - Pathology-Research and …, 2018 - Elsevier
Background and aim Nucleolar and spindle-associated protein 1 (NUSAP1) is an indispensable
mitotic regulator. Aberrant NUSAP1 expression is associated with perturbed mitosis and …

Leptin inhibits PPARγ gene expression in hepatic stellate cells in the mouse model of liver damage

Y Zhou, X Jia, J Qin, C Lu, H Zhu, X Li, X Han… - Molecular and Cellular …, 2010 - Elsevier
Hepatic stellate cell (HSC) activation is a key cellular event in the development of liver fibrosis.
Peroxisome proliferator-activated receptor-γ (PPARγ) has been shown to function as a …

[HTML][HTML] A comparison of traditional and novel methods for the separation of exosomes from human samples

…, JX Liu, F Jiang, WK Ni, LS Qu, RZ Ni, CH Lu… - BioMed research …, 2018 - hindawi.com
Exosomes are discrete populations of small (40-200 nm in diameter) membranous vesicles
that are released into the extracellular space by most cell types, eventually accumulating in …